Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. Announcement on Company Products Being Selected in the Centralized Procurement of Chinese Patent Medicines by the National Procurement Alliance
The Company and the entire Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") participated in the bidding for the centralized volume procurement of Chinese patent medicines by the National Procurement Alliance. According to the "Notice on the Results of the Centralized Procurement of Chinese Patent Medicines by the National Procurement Alliance" issued by the Hubei Medical Security Service Platform on June 17, 2026, the Company's products Yindan Xinnuotong Soft Capsules, Hufu Tablets, and Qiangli Pipaye Dew were selected in this centralized volume procurement of Chinese patent medicines. The relevant situation is hereby announced as follows:
I. Basic Information of Selected Products